Ayaz C, Celen MK, Yuce UN, Geyik MF. Efficacy and safety of pegylated-interferon α-2a in hemodialysis patients with chronic hepatitis C. World J Gastroenterol 2008; 14(2): 255-259 [PMID: 18186564 DOI: 10.3748/wjg.14.255]
Corresponding Author of This Article
Dr. Mustafa Kemal Celen, Dicle University Hospital, Department of Infectious Diseases21280 Diyarbakir, Turkey. mkcelen@hotmail.com
Article-Type of This Article
Rapid Communication
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/